Project Details
Description
N/A
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/14 → 8/1/15 |
Protocol V503-001-04 "A randomized, international, double-blind (internally blinded), internally blinded, controlled by gardasil™, dose range determination on tolerability, immunogenicity, and efficacy of the multivalent l1 virus-like particle (VPL) vaccine against human papillomavirus (HPV) administered to women 16-26 years of age".
Project: Research Project